Common Stock, Shares, Outstanding of Axsome Therapeutics, Inc. from 31 Dec 2015 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Axsome Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2015 to 31 Dec 2025.
  • Axsome Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 50,882,766, a 4.6% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Axsome Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 50,882,766 +2,215,179 +4.6% 31 Dec 2025 10-K 23 Feb 2026 2025 FY
Q3 2025 50,307,834 +1,871,726 +3.9% 30 Sep 2025 10-Q 03 Nov 2025 2025 Q3
Q2 2025 49,815,301 +2,013,723 +4.2% 30 Jun 2025 10-Q 04 Aug 2025 2025 Q2
Q1 2025 49,216,759 +1,752,184 +3.7% 31 Mar 2025 10-Q 05 May 2025 2025 Q1
Q4 2024 48,667,587 +1,316,224 +2.8% 31 Dec 2024 10-K 23 Feb 2026 2025 FY
Q3 2024 48,436,108 +1,118,727 +2.4% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 47,801,578 +1,074,784 +2.3% 30 Jun 2024 10-Q 05 Aug 2024 2024 Q2
Q1 2024 47,464,575 +3,916,109 +9% 31 Mar 2024 10-Q 06 May 2024 2024 Q1
Q4 2023 47,351,363 +3,852,746 +8.9% 31 Dec 2023 10-K 18 Feb 2025 2024 FY
Q3 2023 47,317,381 +3,891,674 +9% 30 Sep 2023 10-Q 06 Nov 2023 2023 Q3
Q2 2023 46,726,794 +6,812,383 +17% 30 Jun 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 43,548,466 +4,665,021 +12% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 43,498,617 +5,681,823 +15% 31 Dec 2022 10-K 23 Feb 2024 2023 FY
Q3 2022 43,425,707 +5,737,824 +15% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 39,914,411 +2,265,463 +6% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 38,883,445 +1,319,563 +3.5% 31 Mar 2022 10-Q 02 May 2022 2022 Q1
Q4 2021 37,816,794 +442,706 +1.2% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 37,687,883 +353,682 +0.95% 30 Sep 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 37,648,948 +381,438 +1% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 37,563,882 +488,460 +1.3% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 37,374,088 +440,871 +1.2% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 37,334,201 +2,837,355 +8.2% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 37,267,510 +2,937,069 +8.6% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 37,075,422 +3,771,375 +11% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 36,933,217 +6,846,004 +23% 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q3 2019 34,496,846 +8,038,184 +30% 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 34,330,441 +8,077,879 +31% 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 33,304,047 +7,754,155 +30% 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 30,087,213 +4,594,221 +18% 31 Dec 2018 10-K 12 Mar 2020 2019 FY
Q3 2018 26,458,662 +2,793,130 +12% 30 Sep 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 26,252,562 +2,644,478 +11% 30 Jun 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 25,549,892 +2,006,225 +8.5% 31 Mar 2018 10-Q 08 May 2018 2018 Q1
Q4 2017 25,492,992 +6,343,575 +33% 31 Dec 2017 10-K 15 Mar 2019 2018 FY
Q3 2017 23,665,532 +4,512,115 +24% 30 Sep 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 23,608,084 +4,458,667 +23% 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 23,543,667 +4,394,250 +23% 31 Mar 2017 10-Q 09 May 2017 2017 Q1
Q4 2016 19,149,417 0 0% 31 Dec 2016 10-K 07 Mar 2018 2017 FY
Q3 2016 19,153,417 30 Sep 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 19,149,417 30 Jun 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 19,149,417 31 Mar 2016 10-Q/A 09 Aug 2016 2016 Q1
Q4 2015 19,149,417 31 Dec 2015 10-K 07 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.